Cargando…
Clinical improvement after change of therapy from tafamidis to patisiran in progressive TTR amyloidosis post-liver transplantation
| Autores principales: | , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Springer Berlin Heidelberg
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9217831/ https://www.ncbi.nlm.nih.gov/pubmed/35124750 http://dx.doi.org/10.1007/s00415-022-10978-3 |
| _version_ | 1784731743604965376 |
|---|---|
| author | Bulinski, Catherine Discher, Thomas Rutsatz, Wiebke Assmus, Birgit Krämer, Heidrun H. |
| author_facet | Bulinski, Catherine Discher, Thomas Rutsatz, Wiebke Assmus, Birgit Krämer, Heidrun H. |
| author_sort | Bulinski, Catherine |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9217831 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | Springer Berlin Heidelberg |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-92178312022-06-24 Clinical improvement after change of therapy from tafamidis to patisiran in progressive TTR amyloidosis post-liver transplantation Bulinski, Catherine Discher, Thomas Rutsatz, Wiebke Assmus, Birgit Krämer, Heidrun H. J Neurol Letter to the Editors Springer Berlin Heidelberg 2022-02-06 2022 /pmc/articles/PMC9217831/ /pubmed/35124750 http://dx.doi.org/10.1007/s00415-022-10978-3 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
| spellingShingle | Letter to the Editors Bulinski, Catherine Discher, Thomas Rutsatz, Wiebke Assmus, Birgit Krämer, Heidrun H. Clinical improvement after change of therapy from tafamidis to patisiran in progressive TTR amyloidosis post-liver transplantation |
| title | Clinical improvement after change of therapy from tafamidis to patisiran in progressive TTR amyloidosis post-liver transplantation |
| title_full | Clinical improvement after change of therapy from tafamidis to patisiran in progressive TTR amyloidosis post-liver transplantation |
| title_fullStr | Clinical improvement after change of therapy from tafamidis to patisiran in progressive TTR amyloidosis post-liver transplantation |
| title_full_unstemmed | Clinical improvement after change of therapy from tafamidis to patisiran in progressive TTR amyloidosis post-liver transplantation |
| title_short | Clinical improvement after change of therapy from tafamidis to patisiran in progressive TTR amyloidosis post-liver transplantation |
| title_sort | clinical improvement after change of therapy from tafamidis to patisiran in progressive ttr amyloidosis post-liver transplantation |
| topic | Letter to the Editors |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9217831/ https://www.ncbi.nlm.nih.gov/pubmed/35124750 http://dx.doi.org/10.1007/s00415-022-10978-3 |
| work_keys_str_mv | AT bulinskicatherine clinicalimprovementafterchangeoftherapyfromtafamidistopatisiraninprogressivettramyloidosispostlivertransplantation AT discherthomas clinicalimprovementafterchangeoftherapyfromtafamidistopatisiraninprogressivettramyloidosispostlivertransplantation AT rutsatzwiebke clinicalimprovementafterchangeoftherapyfromtafamidistopatisiraninprogressivettramyloidosispostlivertransplantation AT assmusbirgit clinicalimprovementafterchangeoftherapyfromtafamidistopatisiraninprogressivettramyloidosispostlivertransplantation AT kramerheidrunh clinicalimprovementafterchangeoftherapyfromtafamidistopatisiraninprogressivettramyloidosispostlivertransplantation |